Multicenter Study on the Evaluation of Adherence, Persistence and Efficacy of Treatment With Inclisiran in Italy
- Sponsor
- Federico II University
- Study ID
- NCT06287177
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Inclisiran — DRUGInjection
Study Details
Evaluation of adherence, persistence and efficacy of treatment with Inclisiran in a real-life Italian population
Key Dates
- Start date
- Nov 1, 2022
- Status verified
- Jan 2026
- Primary completion
- Feb 29, 2024
- Completion
- Nov 1, 2030
Study Design
- Enrollment
- 3,000 participants (estimated)
Arms
- Arm: Subjects with hyperlipidaemia under Inclisiran treatment
Primary Outcome Measure
Description of adherence to treatment with Inclisiran in a real-life Italian population [ Time Frame: at 3 months and every 6 months thereafter ]
Related Studies
- Causes and Natural History of DyslipidemiasRecruiting · National Heart, Lung, and Blood Institute (NHLBI) · Bethesda, Maryland
- Alirocumab in Patients on a Stable Dialysis RegimenPHASE3 · Recruiting · Baylor Research Institute · Dallas, Texas
- Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders TrialPHASE2 · Recruiting · Wake Forest University Health Sciences · Winston-Salem, North Carolina
- Pharmacogenomic Informed Statin PrescribingRecruiting · VA Office of Research and Development · Indianapolis, Indiana